213 related articles for article (PubMed ID: 24343625)
1. Diagnosis and treatment of Paget's disease of bone: a mini-review.
Ferraz-de-Souza B; Correa PH
Arq Bras Endocrinol Metabol; 2013 Nov; 57(8):577-82. PubMed ID: 24343625
[TBL] [Abstract][Full Text] [Related]
2. Zoledronic acid for treatment of Paget's disease of bone.
Devogelaer JP; Manicourt DH
Expert Opin Pharmacother; 2007 Nov; 8(16):2863-9. PubMed ID: 17956205
[TBL] [Abstract][Full Text] [Related]
3. Persistent effect of zoledronic acid in Paget's disease.
Tziomalos K; Florentin M; Krikis N; Perifanis V; Karagiannis A; Harsoulis F
Clin Exp Rheumatol; 2007; 25(3):464-6. PubMed ID: 17631747
[TBL] [Abstract][Full Text] [Related]
4. Normal bone turnover markers in a patient with active Paget's disease of bone: response to treatment with zoledronic acid.
Polyzos SA; Anastasilakis AD; Anagnostis P; Kita M; Arsos G; Moralidis E; Papatheodorou A; Terpos E
Endokrynol Pol; 2012; 63(4):312-5. PubMed ID: 22933168
[TBL] [Abstract][Full Text] [Related]
5. Paget's disease of bone: A clinical update.
Cook SJ; Wall C
Aust J Gen Pract; 2021; 50(1-2):23-29. PubMed ID: 33543158
[TBL] [Abstract][Full Text] [Related]
6. Management of patients with Paget's disease: a consensus document of the Belgian Bone Club.
Devogelaer JP; Bergmann P; Body JJ; Boutsen Y; Goemaere S; Kaufman JM; Reginster JY; Rozenberg S; Boonen S;
Osteoporos Int; 2008 Aug; 19(8):1109-17. PubMed ID: 18504638
[TBL] [Abstract][Full Text] [Related]
7. The use of zoledronic acid for Paget's disease of bone.
Maricic M
Curr Osteoporos Rep; 2006 Mar; 4(1):40-4. PubMed ID: 16527007
[TBL] [Abstract][Full Text] [Related]
8. The use of intravenous aminobisphosphonates for the treatment of Paget's disease of bone.
Gennari L; Merlotti D; Mossetti G; Rendina D; De Paola V; Martini G; Nuti R
Mini Rev Med Chem; 2009 Aug; 9(9):1052-63. PubMed ID: 19689402
[TBL] [Abstract][Full Text] [Related]
9. Symptomatic intracranial hypertension and prolonged hypocalcemia following treatment of Paget's disease of the skull with zoledronic acid.
Ferraz-de-Souza B; Martin RM; Correa PH
J Bone Miner Metab; 2013 May; 31(3):360-5. PubMed ID: 23076294
[TBL] [Abstract][Full Text] [Related]
10. Paget's disease of bone and calcium homeostasis: focus on bisphosphonate treatment.
Polyzos SA; Anastasilakis AD; Makras P; Terpos E
Exp Clin Endocrinol Diabetes; 2011 Oct; 119(9):519-24. PubMed ID: 21811962
[TBL] [Abstract][Full Text] [Related]
11. A review of Paget's disease of bone with a focus on the efficacy and safety of zoledronic acid 5 mg.
Abelson A
Curr Med Res Opin; 2008 Mar; 24(3):695-705. PubMed ID: 18226324
[TBL] [Abstract][Full Text] [Related]
12. Bisphosphonates for Paget's disease of bone in adults.
Corral-Gudino L; Tan AJ; Del Pino-Montes J; Ralston SH
Cochrane Database Syst Rev; 2017 Dec; 12(12):CD004956. PubMed ID: 29192423
[TBL] [Abstract][Full Text] [Related]
13. [Treatment of Paget's disease of bone with zoledronic acid].
Body JJ; Sternon J
Rev Med Brux; 2005; 26(6):513-7. PubMed ID: 16454155
[TBL] [Abstract][Full Text] [Related]
14. Zoledronic acid: a review of its use in the treatment of Paget's disease of bone.
Keating GM; Scott LJ
Drugs; 2007; 67(5):793-804. PubMed ID: 17385948
[TBL] [Abstract][Full Text] [Related]
15. Profound hypocalcemia following effective response to zoledronic acid treatment in a patient with juvenile Paget's disease.
Polyzos SA; Anastasilakis AD; Litsas I; Efstathiadou Z; Kita M; Arsos G; Moralidis E; Papatheodorou A; Terpos E
J Bone Miner Metab; 2010 Nov; 28(6):706-12. PubMed ID: 20533067
[TBL] [Abstract][Full Text] [Related]
16. Scintigraphic, biochemical, and clinical response to zoledronic acid treatment in patients with Paget's disease of bone.
Avramidis A; Polyzos SA; Moralidis E; Arsos G; Efstathiadou Z; Karakatsanis K; Grollios G; Kita M
J Bone Miner Metab; 2008; 26(6):635-41. PubMed ID: 18979164
[TBL] [Abstract][Full Text] [Related]
17. [Paget's disease: case report].
Wegierska M; Ignaczak P; Zalewska J; Jeka S
Ann Acad Med Stetin; 2011; 57(3):64-9; discussion 69. PubMed ID: 23383549
[TBL] [Abstract][Full Text] [Related]
18. Zoledronic acid for Paget's disease of bone.
Maricic M
Drugs Today (Barc); 2007 Dec; 43(12):879-85. PubMed ID: 18174973
[TBL] [Abstract][Full Text] [Related]
19. Drug treatment strategies for paget's disease: relieving pain and preventing progression.
Merlotti D; Rendina D; Cavati G; Abate V; Falchetti A; Mingiano C; Nuti R; Gennari L
Expert Opin Pharmacother; 2023 Apr; 24(6):715-727. PubMed ID: 36961938
[TBL] [Abstract][Full Text] [Related]
20. Paget's disease of bone: analysis of 134 cases from an island in Southern Brazil: another cluster of Paget's disease of bone in South America.
Werner de Castro GR; Heiden GI; Zimmermann AF; Morato EF; Neves FS; Toscano MA; de Magalhães Souza Fialho SC; Pereira IA
Rheumatol Int; 2012 Mar; 32(3):627-31. PubMed ID: 21127877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]